SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

REMEDIUM LIFECARE

BSE: 539561 28 Jun 2025
Services
₹ 0.88
REMEDIUM LIFECARE LIMITED specializes in Trading & Distributors within the Services sector.

REMEDIUM LIFECARE - Share Price & Details

Market Cap
₹81.1
High /Low
63.4 / 0.87
Stock P/E
53.0
Book Value
₹0.48
Dividend Yield
0.0
ROCE
1.39
ROE
₹3.55
Face Value
1.0
PEG Ratio
1.31
EVEBITDA
₹136.0
Debt
1,141
CMP / FCF
-0.21
Debt to equity
₹26.4
NP Ann
1.53
High price all time
132.0
Piotroski score
₹3.0
Graham Number
0.43
No. Eq. Shares
88.2
Net CF
₹-0.16
Net profit
1.53
Price to book value
1.9
Interest Coverage
₹1.69
Low price all time
0.29
Industry PE
32.6
Reserves
₹2.98
Free Cash Flow
₹-1,079

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Alna Trading & Exports Ltd.,NANANANA0
Oseaspre Consultants Ltd.,NANANANA0
REMEDIUM LIFECARE LIMITEDNANANANA81.153.0
AMRAPALI INDUSTRIES LTD.NANANANA7948.2
EAST WEST FREIGHT CARRIERS LTDNANANANA77.460.0

Peer Comparison Chart


About REMEDIUM LIFECARE

REMEDIUM LIFECARE LIMITED, with Security Code 539561, is a leading player in the Trading & Distributors industry, categorized under the Services sector, offering Equity instruments.


Latest News

Remedium Lifecare Ltd Faces Intense Selling Pressure Amid Significant Price Declines

(12 Jun 2025)
Remedium Lifecare Ltd is experiencing intense selling pressure, with its stock declining significantly over the past week and hitting a new all-time low.
Read more →

Remedium Lifecare Faces Intense Selling Pressure Amid Significant Stock Price Declines

(10 Jun 2025)
Remedium Lifecare Ltd is experiencing significant selling pressure, with its stock declining sharply over various time frames.
Read more →

Remedium Lifecare reports standalone net loss of Rs 2.64 crore in the March 2025 quarter

(05 Jun 2025)
Sales decline 94.21% to Rs 81.57 crore. Net Loss of Remedium Lifecare reported to Rs 2.64 crore in the quarter ended March 2025 as against...
Read more →

Remedium Lifecare Faces Intense Selling Pressure Amid Significant Price Declines

(05 Jun 2025)
Remedium Lifecare Ltd is experiencing notable selling pressure, with a five-day decline resulting in a 15.14% loss. The stock has underperformed against the...
Read more →

Remedium Lifecare Emerges as a Resilient, High-Growth Opportunity amid Concerns Over Trump’s Pharma Tariffs

(29 May 2025)
As speculation grows over potential pharmaceutical tariffs, global pharma stocks are experiencing renewed volatility.
Read more →

Remedium Lifecare Ltd Sees Strong Buying Activity Amid Broader Market Decline

(29 May 2025)
Remedium Lifecare Ltd is experiencing notable buying activity, with a significant rise in its stock price today, contrasting with a decline in the Sensex.
Read more →